Es gab 50 kürzliche Insider-Transaktionen für NexImmune, Inc. (NEXI), darunter 34 Käufe und 14 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.67M und die gesamten Insider-Verkäufe auf $3.08M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Jones Kristi, Marchio Albert N Ii, Roemer Alan S.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NEXI
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-06-11 |
Jones Kristi |
President and CEO |
Informierter Kauf |
1 |
$0.01 |
$0.01 |
1 |
| 2024-04-05 |
Marchio Albert N Ii |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-11-22 |
Roemer Alan S. |
Director |
Informierter Verkauf |
3,992 |
$1.94 |
$7.76K |
- |
| 2023-11-21 |
Roemer Alan S. |
Director |
Informierter Verkauf |
3,833 |
$2.16 |
$8.29K |
3,992 |
| 2023-08-30 |
Stover Timothy |
VP, Corporate Controller |
Veräußerung |
6,375 |
$1.03 |
$6.57K |
- |
| 2023-07-05 |
Barer Sol J |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
Yao Zhengbin |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
Bertram Timothy |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
Roemer Alan S. |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
D'angio Paul |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
Verstandig Grant |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-07-05 |
Gandhi Leena |
Director |
RSU-Zuteilung |
44,983 |
$0.29 |
$13.05K |
44,983 |
| 2023-04-04 |
Barer Sol J |
Director |
Aktienrückgabe |
155,900 |
$5.17 |
$806K |
- |
| 2023-04-04 |
Yao Zhengbin |
Director |
Aktienrückgabe |
9,556 |
$17.00 |
$162.45K |
- |
| 2023-04-04 |
Bertram Timothy |
Director |
Aktienrückgabe |
61,678 |
$1.82 |
$112.25K |
- |
| 2023-04-04 |
Roemer Alan S. |
Director |
Aktienrückgabe |
3,856 |
$4.31 |
$16.62K |
- |
| 2023-04-04 |
D'angio Paul |
Director |
Aktienrückgabe |
61,678 |
$1.82 |
$112.25K |
- |
| 2023-04-04 |
Verstandig Grant |
Director |
Aktienrückgabe |
39,096 |
$17.00 |
$664.63K |
- |
| 2023-04-04 |
Trainer John |
Chief Financial Officer |
Aktienrückgabe |
78,100 |
$4.22 |
$329.58K |
- |
| 2023-04-04 |
Jones Kristi |
President and CEO |
Aktienrückgabe |
88,156 |
$2.58 |
$227.44K |
- |
| 2023-04-04 |
Oelke Mathias |
Chief Science Officer |
Aktienrückgabe |
15,793 |
$2.42 |
$38.22K |
- |
| 2023-04-04 |
Gandhi Leena |
Director |
Aktienrückgabe |
80,947 |
$3.07 |
$248.51K |
- |
| 2023-03-30 |
Barer Sol J |
Director |
Informierter Kauf |
400,000 |
$0.41 |
$164.12K |
2,217,814 |
| 2022-11-26 |
Jones Kristi |
President and CEO |
RSU-Zuteilung |
296,700 |
- |
- |
369,778 |
| 2022-11-22 |
Trainer John |
Chief Financial Officer |
RSU-Zuteilung |
125,200 |
- |
- |
186,969 |
| 2022-11-22 |
Oelke Mathias |
Chief Science Officer |
RSU-Zuteilung |
126,100 |
- |
- |
134,023 |
| 2022-11-17 |
Barer Sol J |
Director |
Informierter Kauf |
75,000 |
$0.48 |
$35.92K |
1,817,814 |
| 2022-11-16 |
Barer Sol J |
Director |
Informierter Kauf |
125,000 |
$0.48 |
$60.3K |
1,742,814 |
| 2022-06-13 |
Barer Sol J |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-13 |
Yao Zhengbin |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-13 |
Bertram Timothy |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-13 |
Roemer Alan S. |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-13 |
D'angio Paul |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-13 |
Verstandig Grant |
Director |
RSU-Zuteilung |
61,678 |
- |
- |
61,678 |
| 2022-06-03 |
Verstandig Grant |
Director |
Informierter Kauf |
25,000 |
$2.14 |
$53.54K |
1,078,619 |
| 2022-05-31 |
Barer Sol J |
Director |
Informierter Kauf |
39,280 |
$2.19 |
$85.89K |
1,557,094 |
| 2022-05-31 |
Verstandig Grant |
Director |
Informierter Kauf |
40,200 |
$2.38 |
$95.76K |
990,719 |
| 2022-05-05 |
Gandhi Leena |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-05-05 |
Gandhi Leena |
Director |
RSU-Zuteilung |
80,947 |
- |
- |
80,947 |
| 2022-04-05 |
Zeldis Jerome B |
Executive VP of Research & Dev |
RSU-Zuteilung |
80,100 |
$4.22 |
$338.02K |
80,100 |
| 2022-04-05 |
Trainer John |
Chief Financial Officer |
RSU-Zuteilung |
78,100 |
- |
- |
78,100 |
| 2022-04-05 |
Jones Kristi |
President and CEO |
RSU-Zuteilung |
456,000 |
- |
- |
456,000 |
| 2022-04-05 |
Knight Robert Douglas |
Chief Medical Officer |
RSU-Zuteilung |
48,000 |
- |
- |
48,000 |
| 2022-04-05 |
Oelke Mathias |
Chief Science Officer |
Veräußerung |
19,905 |
$17.00 |
$338.39K |
- |
| 2022-04-05 |
Oelke Mathias |
Chief Science Officer |
RSU-Zuteilung |
60,000 |
- |
- |
60,000 |
| 2022-03-29 |
Jones Kristi |
President and CEO |
Informierter Kauf |
10,000 |
$3.74 |
$37.4K |
73,078 |
| 2022-03-24 |
Verstandig Grant |
Director |
Informierter Kauf |
131,622 |
$4.14 |
$544.92K |
886,512 |
| 2022-03-23 |
Barer Sol J |
Director |
Informierter Kauf |
10,000 |
$2.67 |
$26.65K |
1,517,814 |
| 2022-03-22 |
Barer Sol J |
Director |
Informierter Kauf |
30,000 |
$2.41 |
$72.3K |
1,507,814 |
| 2022-03-21 |
Barer Sol J |
Director |
Informierter Kauf |
30,000 |
$2.14 |
$64.08K |
1,477,814 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall